High Intensity Focused Ultrasound Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Hifu
HIFU (High Intensity Focused Ultrasound) is a therapy option for BPH or prostate cancer (in some countries) that uses focused ultrasound waves to create intense heat at a specific site. Learn more about this prostate treatment option. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - June 5, 2013 Category: Cancer & Oncology Tags: health Source Type: news
Center of Excellence for HIFU Surgical Ablation Technology
SonaCare Medical, a global leader in minimally invasive HIFU technologies, announced today that it has partnered with University College London (UCL) to create a HIFU Center of Excellence.05/03/2013 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - May 3, 2013 Category: Cancer & Oncology Source Type: news
SonaCare to incorporate SmartTarget into its HIFU system
High-intensity focused ultrasound (HIFU) developer SonaCare Medical plans to (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 1, 2013 Category: Radiology Source Type: news
High Intensity Focused Ultrasound Transducer
We provide semi-custom, modular, and pure custom ultrasonic transducer products for High Intensity Focused Ultrasound applications. Each solution is designed for your specific applications. (Source: PhysicsWeb Products and Press)
Source: PhysicsWeb Products and Press - April 25, 2013 Category: Physics Source Type: news
USHIFU changes name to SonaCare
High-intensity focused ultrasound (HIFU) developer USHIFU announced it has (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 22, 2013 Category: Radiology Source Type: news
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
Munich Study Concludes 15 Year Outcome Data May Warrant Closing of Investigational Phase for HIFU
LYON, France, Feb. 22, 2013 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today n... Devices, Urology, OncologyEDAP TMS SA, HIFU therapy, Ablatherm, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2013 Category: Pharmaceuticals Source Type: news
Imaging and Focal Therapy of Early Prostate Cancer
series:Current Clinical UrologyImaging and Focal Therapy of Early Prostate Cancer evaluates the scientific evidence for the evolving trend to treat low to intermediate risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. Various ablative devices such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and ... (Source: Springer Medicine titles)
Source: Springer Medicine titles - February 11, 2013 Category: Databases & Libraries Tags: Urology / Andrology Source Type: news
EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period
Longest Retrospective Study of HIFU Patients to Date Published Confirms Benefits of Treatment
LYON, France, Feb. 8, 2013 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today new da... Devices, OncologyEDAP TMS, Ablatherm-HIFU, ultrasound guided HIFU, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2013 Category: Pharmaceuticals Source Type: news
EDAP TMS Gets CE Mark For Proprietary HIFU Technology
EDAP TMS S.A. announced that it has received the CE Mark for its proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of localized prostate cancer (Source: Medical Design Online News)
Source: Medical Design Online News - January 1, 1996 Category: Medical Devices Source Type: news